Institutional investors hold 65% of Harvard Bioscience, Inc. (NASDAQ:HBIO), influencing stock dynamics. Top 10 investors own 52%, with hedge funds and CEO James Green also holding significant stakes.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing